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Fruit and vegetable intake and cardiovascular risk factors in
people with newly diagnosed type 2 diabetes
MJE Lamb1, SJ Grifﬁn1,2, SJ Sharp1 and AJM Cooper1
BACKGROUND/OBJECTIVES: The cardiovascular beneﬁt of increasing fruit and vegetable (F&V) intake following diagnosis of
diabetes remains unknown. We aimed to describe how quantity and variety of F&V intake, and plasma vitamin C, change after
diagnosis of type 2 diabetes and examine whether these changes are associated with improvements in cardiovascular risk factors.
SUBJECTS/METHODS: A total of 401 individuals with screen-detected diabetes from the ADDITION-Cambridge study were
followed up over 5 years. F&V intake was assessed by food frequency questionnaire and plasma vitamin C at baseline, at 1 year and
at 5 years. Linear mixed models were used to estimate associations of changes in quantity and variety of F&V intake, and plasma
vitamin C, with cardiovascular risk factors and a clustered cardiometabolic risk score (CCMR), where a higher score indicates
higher risk.
RESULTS: F&V intake increased in year 1 but decreased by year 5, whereas variety remained unchanged. Plasma vitamin C
increased at 1 year and at 5 years. Each s.d. increase (250g between baseline and 1 year and 270g between 1 and 5 years) in F&V
intake was associated with lower waist circumference (−0.92 (95% CI: − 1.57, − 0.27) cm), HbA1c (−0.11 (−0.20, − 0.03) %) and CCMR
(−0.04 (−0.08, − 0.01)) at 1 year and higher high-density lipoprotein (HDL)-cholesterol (0.04 (0.01, 0.06) mmol/l) at 5 years. Increased
plasma vitamin C (per s.d., 22.5 μmol/l) was associated with higher HDL-cholesterol (0.04 (0.01, 0.06) mmol/l) and lower CCMR
(−0.07 (−0.12, − 0.03)) between 1 and 5 years.
CONCLUSIONS: Increases in F&V quantity following diagnosis of diabetes are associated with lower cardiovascular risk factors.
Health promotion interventions might highlight the importance of increasing, and maintaining increases in, F&V intake for
improved cardiometabolic health in patients with diabetes.
European Journal of Clinical Nutrition (2017) 71, 115–121; doi:10.1038/ejcn.2016.180; published online 19 October 2016
INTRODUCTION
Type 2 diabetes is a leading cause of premature morbidity and
mortality, much of which can be explained by the increased risk of
cardiovascular disease (CVD).1,2 Previous studies have shown that
adhering to speciﬁc dietary patterns such as the Dietary
Approaches to Stop Hypertension diet (DASH-diet) or the
Mediterranean Diet can lower the risk of developing CVD, even
among those initially at high such as, individuals with diabetes.3–5
A common theme underpinning these diets is an emphasis on
consuming more fruits and vegetables (F&V). A large number of
studies have demonstrated independent health beneﬁts of a diet
rich in F&V,6–8 ﬁndings that are supported by several studies that
examined associations using plasma vitamin C as an objective
biomarker of F&V intake.9,10 More recently, variety of F&V intake,
independent of quantity, has been considered in relation to risk of
diabetes and CVD.11–13 To our knowledge, no studies have
examined the relationship between repeat measures of quantity
and variety of F&V intake and CVD risk factors among individuals
with diabetes over 5 years of follow-up, corroborated using
plasma vitamin C levels.
Using data from the Anglo–Danish–Dutch Study of Intensive
Treatment In People with Screen-Detected Diabetes in Primary
Care (ADDITION)-Cambridge study, we examined the longitudinal
relationship between quantity and variety of F&V intake and
plasma vitamin C levels with CVD risk factors in participants with
diabetes who were followed up for 5 years.
METHODS
Study design
The design and rationale for the ADDITION-Cambridge study have been
reported in detail elsewhere.14 In brief, individuals were recruited from 49
general practice clinics in the East of England, UK, for a stepwise diabetes
screening programme. Diabetes was diagnosed according to WHO
criteria.15 Eligible individuals were aged 40–69 years with no known
diabetes and were within the top 25% of a diabetes risk score.14,16
Exclusion criteria included being pregnant or lactating, having an illness
with a prognosis of death within 1 year or a psychiatric illness that was
likely to preclude involvement or informed consent. Of the 33 539
individuals who were invited to attend screening, 867 were identiﬁed to
have diabetes and agreed to participate in the randomised control trial.
The aim of the trial was to compare intensive treatment of multiple risk
factors with routine care in individuals with screen-detected diabetes.
Participants were cluster-randomised by general practice clinic. In the
intensive treatment group, practitioners were encouraged to follow a
stepwise target-led treatment regimen to reduce and control CVD risk
factors including blood glucose and lipid levels. This group additionally
received theory-based health promotion materials including encourage-
ment to consume at least ﬁve portions of F&V per day. The routine care
group received care, which followed UK national guidelines for diabetes
management.17 Participants attended for follow-up health assessments
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after 1 and 5 years. As there was no interaction by trial group, we pooled
both trial groups and conducted a cohort analysis.
Ethical approval was obtained from the Eastern Multi-Centre Research
Ethics Committee (reference number 02/5/54), and all participants gave
written informed consent. The ADDITION-Cambridge trial is registered as
ISRCTN86769081.
Fruit and vegetable intake and plasma vitamin C levels
Plasma vitamin C, an objective biomarker of F&V intake,9,18 was measured
using a Fluoroskan Ascent FL ﬂuorometer. Self-reported F&V intake was
assessed using a validated 130-item food frequency questionnaire (FFQ).19
Participants were asked to report the frequency of food consumption on a
nine-point scale ranging from ‘never or less than once per month’ to ‘more
than six times per day’. Variety of F&V intake was derived by summing the
total number of unique fruit and vegetable items consumed at least once
per week. Possible variety ranged from 0 to 37 items. Quantity of F&V
intake was derived by summing the total quantity (in grams/day) of
different F&V consumed over the period of 1 week, divided by seven to
quantify daily intake. We did not include potatoes in our analyses, as they
differ from vegetables in terms of energy and carbohydrate content and
are commonly substituted for cereals rather than vegetables.20 We also did
not include fruit juice, as it is not considered to be equivalent to whole fruit
regarding ﬁbre content and satiety value.21
Measurement of cardiovascular risk factors
Baseline, 1 year and 5 year health assessment visits to the study clinic
included clinical and anthropometric measures. HbA1c was measured in
venous samples using an ion-exchange high-performance liquid
chromatography method (Tosoh Bioscience, Redditch, UK). Serum total
cholesterol, high-density lipoprotein (HDL)-cholesterol and triglycerides
were measured in non-fasted samples using enzymatic techniques
(Dade Behring Dimension analyser, Newark). Blood pressure was
determined based on the mean of three measurements performed after
10 min of rest, while participants were seated with a cuff placed on their
predominant arm at the level of the heart, using an automated
sphygmomanometer (Omron M4, UK). Height and weight were
measured in light clothing, without shoes, using a ﬁxed rigid
stadiometer and scale (SECA, UK). Waist circumference was derived
based on the mean of two measurements taken with a tape measure
halfway between the lowest point of the rib cage and the anterior
superior iliac crest while standing.
Clustered cardiometabolic risk scores (CCMR) were derived for all clinic
visits by averaging standardised values for waist circumference, systolic
blood pressure, HbA1c, the natural log of triglycerides and the inverse of
HDL-cholesterol. Variables were standardised by subtracting from them
sex-speciﬁc population means and dividing by sex-speciﬁc s.d.’s. Means
and s.d.’s at baseline were used to standardise all follow-up CCMR scores.
A lower score therefore indicates lower risk.
Covariates
Self-report questionnaires were used to obtain information on age, sex,
occupation and ethnicity. Occupational social class was deﬁned
according to the Registrar General’s occupation-based classiﬁcation
and comprised three categories: ‘professional, managerial and technical’,
‘skilled – manual and non-manual’ and ‘partly skilled or unskilled’. Total
energy and alcohol intake were assessed using an FFQ.19 Time spent in
moderate-to-vigorous physical activity was assessed by self-report using
the previously validated European Prospective Investigation into Cancer-
Norfolk physical activity questionnaire (EPAQ-2).22 Medication use was
assessed using a self-report questionnaire adapted from the Aberdeen
Health Service Research Unit questionnaire.14 Very few people reported
taking multivitamin supplements; therefore, this was not included in the
analysis.
Statistical analysis
Descriptive characteristics at baseline and at 1 and 5 years of follow-up
were summarised using means and s.d.’s or frequencies and percentages.
t-tests or χ2 tests were used to examine differences in participant
characteristics between those included for these analyses and those
excluded because of missing data.
Linear mixed models, with participant-speciﬁc random intercepts,
were used to estimate the associations between each s.d. increase in
change in quantity of F&V intake from baseline to 1 year, and from 1 to 5
years, with CVD risk factor levels and CCMR at 1 and 5 years, respectively.
Models were adjusted for age and sex (model 1), exposure and outcome
at baseline or 1 year (where applicable), intervention group, occupa-
tional social class, smoking status, alcohol intake, total energy intake and
self-reported moderate-to-vigorous physical activity at each baseline
and follow-up (model 2). We additionally adjusted for use of blood
pressure-lowering, lipid-lowering and glucose-lowering medications at
each baseline and follow-up in model 2, as appropriate. The same
approach was used to examine the associations for variety of F&V intake,
as well as for plasma vitamin C levels. Associations of quantity of intake
were adjusted for variety and vice versa.
We assessed for interaction of each exposure with sex in model 2.
To examine whether associations were mediated by changes in waist
circumference (when waist circumference was not the outcome), we
additionally adjusted for changes in waist circumference in model 2. We
also examined whether associations with CCMR were primarily driven by
an association with waist circumference by generating a CCMR score
excluding waist circumference (CCMR•excluding•waist) and with additional
adjustment for waist circumference.
Sensitivity analyses
As the main analyses were limited to individuals who had data for all
variables included in the CCMR score, we also repeated all analyses for
each of the cardiometabolic risk factors independently by including the
largest number of participants with data for that risk factor. To explore
the impact of missing covariate data on our results, we also used
multiple imputation by chained equations. For each exposure–outcome
relationship, 10 imputed data sets were created, and parameter
estimates were combined using Rubin’s rules. Each imputation model
included both the outcome of interest and all covariates in the analysis
models.
All statistical analyses were performed using Stata/SE 13.1 (Stata-Corp,
College Station, TX, USA).
RESULTS
In total, 603 individuals attended all three clinic visits, of
whom 401 had complete data for F&V intake, cardiometabolic
risk factor levels and covariates (Supplementary Figure 1). A total
of 177 individuals were in the intensive treatment trial group
and 224 in the routine care trial group. The mean age of the
study participants was 61.4 (s.d. 6.6) years at baseline. Men
comprised 57% of the cohort (Table 1). Participants with missing
follow-up data tended to have a larger waist circumference and
higher HbA1c levels at baseline compared with those with
complete data. Those with missing data also reported consum-
ing a lower quantity and variety of F&V and had lower plasma
vitamin C levels at baseline and at one and ﬁve years of
follow-up.
As shown in Table 1, intake of F&V increased in both men and
women over the ﬁrst year of follow-up but decreased between
1 and 5 years. The most commonly eaten fruits were apples,
oranges and bananas, and the most commonly eaten vegetables
were carrots, peas, tomatoes and green salad. Variety of F&V
intake remained unchanged over 1 and 5 years of follow-up.
Plasma vitamin C levels increased across follow-ups. Quantity and
variety of F&V intake were moderately correlated at each time
point (r= 0.54, 0.45 and 0.40 at baseline, 1 and 5 years,
respectively). There was a weak correlation between quantity of
vegetable intake and plasma vitamin C (r= 0.10–0.19, at all time
points) and a slightly stronger correlation between fruit and
combined fruit and vegetable intake and plasma vitamin C
(r= 0.24–0.30, at all time points).
There was no suggestion of interaction by sex (P40.05), and
thus all results are presented for men and women combined. Each
s.d. change in quantity of F&V intake between baseline and 1 year
(250 g) was independently associated with a 0.92 (95% CI: 0.27,
1.57) cm lower waist circumference, a 0.11 (0.03, 0.20) % lower
HbA1c level and a 0.04 (0.01, 0.08) lower CCMR score at 1 year
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(Table 2). Except for HDL-c, F&V intake was not associated with any
other CVD risk factor between 1 and 5 years. Change in the
quantity of fruit intake (per s.d., 192 g) was associated with a lower
waist circumference (−0.89 (−1.56, − 0.23) cm), HbA1c level (−0.12
(−0.20, − 0.03) %) and CCMR (0.04 (0.01, 0.08)) at 1 year, as well as
lower triglyceride levels (−0.10 (−0.19, − 0.01) mmol/l) and higher
HDL-c (0.03 (0.01, 0.05) mmol/l) at 5 years (per s.d., 197 g). In
contrast, change in quantity of vegetable intake (per s.d., 151 g)
was associated with a 1.89 (0.29, 3.48) mm Hg lower systolic blood
pressure at 1 year. Increases in plasma vitamin C were not
associated with any of the CVD risk factors or with CCMR between
baseline and one-year (Table 2). Between 1 and 5 years, however,
each s.d. increase in plasma vitamin C (22.5 μmol/l) was associated
with lower triglyceride levels (−0.11 (−0.21, − 0.01 mmol/l),
CCMR (−0.07 (–0.12, –0.03)) and with higher HDL-c levels
(0.04 (0.01, 0.06) mmol/l).
Additional adjustment for waist circumference had no effect
on the observed associations. Associations between change
in combined F&V intake and fruit intake separately with
CCMR•excluding•waist were not statistically signiﬁcant between
baseline and 1 year but were signiﬁcant between 1 and 5 years.
The results were similar after adjustment for waist circumference
in the CCMR•excluding•waist model. The associations between change
in plasma vitamin C and CCMR•excluding•waist did not differ from the
CCMR score including waist circumference (data not shown).
As shown in Table 3, changes in variety of F&V intake combined
and separately were not associated with any of the individual
cardiometabolic risk factors or CCMR at 1 or 5 years.
Our ﬁndings remained unchanged when we included all
participants who had complete data for the cardiometabolic risk
factor being analysed (data not shown) and when we performed
the analyses following multiple imputation of covariate data
(data not shown).
DISCUSSION
We demonstrate that although patients with screen-detected
diabetes tend to increase the quantity of F&V they consume in the
ﬁrst year following diagnosis of diabetes, this increase is not the
result of a change in the variety of F&V consumption, and it is not
maintained long-term. Nevertheless, we show, for the ﬁrst time,
that even modest increases in F&V intake are associated with
clinically meaningful improvements in a number of important
CVD risk factor levels, namely waist circumference, HbA1c and
Table 1. Characteristics of the study population
Baseline 1 year 5 years
N 401 – –
Men (%) 227, 56.6% – –
Age (years) 61.4± 6.6 62.5± 6.6 66.6± 6.7
Height (m) 168.0± 9.4 167.7± 9.4 167.1± 9.5
Weight (kg) 93.1± 17.4 90.0± 17.4 89.7± 18.1
Waist (cm) 110.4± 13.2 107.6± 12.9 107.0± 13.6
SBP (mmHg) 141.5± 20.1 135.2± 19.1 134.6± 16.5
HDL (mmol/l) 1.20± 0.32 1.23± 0.33 1.30± 0.33
TG (mmol/l) 1.7 (1.2, 2.4) 1.6 (1.1, 2.3) 1.6 (1.2, 2.3)
HbA1c (%) 6.7 (6.2, 7.3) 6.3 (5.9, 6.7) 6.8 (6.4, 7.4)
HbA1c (mmol/mol) 49.7 (44.3, 56.3) 45.4 (41.0, 49.7) 50.8 (46.5, 57.4)
CCMR − 0.04± 0.51 − 0.3± 0.5 − 0.3± 0.5
Glucose-lowering drugs (n %) 1, 0.2% 123, 30.7% 242, 60.3%
Blood-pressure-lowering drugs (n %) 288, 71.8% 324, 80.8% 329, 82.0%
Lipid-lowering drugs (n %) 117, 29.2% 298, 74.3% 339, 84.5%
Smoking (n %)
Current 53, 13.2 50, 12.4 45, 11.2
Ex 198, 49.4 201, 50.1 200, 49.9
Never 150, 37.4 150, 37.4 156, 38.9
Alcohol (g/day) 4.68 (0.51, 11.33) 4.66 (0.00, 10.07) 1.55 (0.00, 9.10)
Energy intake (kcal/day) 1918.4± 617.6 1681.6± 528.7 1653.1± 538.8
MVPA (mins/day) 72.1 (30.0, 146.3) 81.4 (31.6, 159.9) 74.4 (29.1, 148.7)
Occupational social class – –
Managerial and professional 144, 35.9%
Intermediate 93, 23.2%
Routine and manual 164, 40.9%
Plasma vitamin C (μmol/l), n= 277 55.0 (39.0, 68.7) 56.7 (40.6, 72.2) 58.0 (39.9, 70.9)
Variety (number per week)
F&V 23.3± 6.2 24.1± 5.9 23.3± 6.0
Fruit 6.7± 2.6 7.0± 2.4 6.6± 2.5
Vegetable 16.6± 4.5 17.1± 4.2 16.7± 4.3
Quantity (g/day)
F&V 489.5 (336.2, 690.6) 555.1 (412.1, 746.7) 495.8 (365.7, 662.5)
Fruit 216.7 (110.9, 362.9) 259.0 (163.8, 399.7) 223.7 (112.1, 361.9)
Vegetable 262.5 (187.4, 340.2) 283.5 (201.9, 367.1) 264.0 (189.3, 350.8)
Abbreviations: CCMR, clustered cardiometabolic risk scores; F&V, fruits and vegetables; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein;
IQR, interquartile range; MVPA, moderate-to-vigorous physical activity; SBP, systolic blood pressure; TG, triglycerides. Values are presented as mean± s.d., n,
% and median (IQR) – denotes that the values are the same as baseline.
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HDL-cholesterol. Increased vegetable intake is associated with
improved systolic blood pressure, whereas increased fruit intake is
associated with improved triglyceride levels. These ﬁndings are
corroborated by the inverse association between change in
plasma vitamin C and overall CCMR.
Although previous studies have examined the associations
between quantity of F&V intake and CVD,23 few have done so in a
population of people with diabetes with an extended duration of
follow-up,24,25 and none have examined the association using
plasma vitamin C as a biomarker of F&V intake. Among 10 000
individuals with diabetes who were followed up for nine years in
the European Prospective Investigation into Cancer and Nutrition
(EPIC) study, each 80 g increase in self-reported F&V intake
(including legumes) was associated with a hazard ratio (HR) of 0.88
(95% CI: 0.81, 0.95) for CVD mortality, whereas each 80 g increase
in fruit was associated with an HR of 0.90 (0.81, 0.91).24 In contrast,
among 1400 Japanese adults with diabetes who were followed up
for 8 years, Tanaka et al.25 did not ﬁnd an association between
self-reported F&V intake and incident coronary heart disease,
although a protective effect on incident stroke was reported.
However, because F&V intake was assessed only at baseline in
both studies, the potential beneﬁts of increases in intake could not
be examined.
To our knowledge, only two other studies have investigated
associations between variety of F&V intake and CVD risk, and
although they were both in non-diabetes-speciﬁc populations
neither was able to ﬁnd an association with incident coronary
heart disease, despite sample sizes of 20 000 and 143 000 with
follow-up durations of 10 and 20 years, respectively.13,12
Consistent with our ﬁnding that increased fruit intake was
associated with a smaller waist circumference over 1 year, Bertoia
et al.26 show that each increase in daily serving of fruit and
vegetable is associated with a 240 g and 110 g reduction in
weight, respectively, over 4 years of follow-up. To put only this
ﬁnding into clinical context, if everybody with newly developed
diabetes were to increase their quantity of F&V intake by 250 g
Table 2. Associations between changes in quantity of F&V intake and changes in plasma vitamin C (per s.d.) with cardiometabolic risk factors at the
relevant follow-up time point, presented as regression coefﬁcients (and 95% conﬁdence intervals) per 1 s.d. increase in the exposure, estimated from
linear mixed models
Baseline to 1 year 1–5 years
Model 1 Model 2 Model 1 Model 2
Waist (cm)
Plasma vitamin C − 0.66 (−1.51, 0.20) − 0.62 (−1.31, 0.08) − 0.31 (−1.13, 0.52) − 0.50 (−1.25, 0.25)
Quantity of F&V − 0.59 (−1.32, 0.13) − 0.92 (−1.57, − 0.27) 0.12 (−0.60, 0.85) − 0.09 (−0.78, 0.60)
Quantity of fruit − 0.69 (−1.45, 0.07) − 0.89 (−1.56, − 0.23) 0.17 (−0.59, 0.93) − 0.28 (−0.96, 0.40)
Quantity of vegetable − 0.18 (−0.88, 0.53) − 0.48 (−1.13, 0.16) 0.06 (−0.64, 0.77) 0.23 (−0.47, 0.93)
SBP (mm Hg)
Plasma vitamin C − 1.27 (−2.98, 0.44) − 1.36 (−3.09, 0.37) − 0.37 (−2.21, 1.47) − 0.99 (−2.86, 0.88)
Quantity of F&V − 0.64 (−2.24, 0.95) − 0.73 (−2.36, 0.90) 0.38 (−1.21, 1.97) 0.31 (−1.43, 2.05)
Quantity of fruit − 0.26 (−1.87, 1.34) 0.44 (−1.23, 2.10) 0.70 (−0.90, 2.30) 0.89 (−0.81, 2.59)
Quantity of vegetable − 0.90 (−2.49, 0.68) − 1.89 (−3.48, − 0.29) − 0.23 (−1.81, 1.35) − 0.62 (−2.36, 1.11)
HbA1c(%)
Plasma vitamin C − 0.00 (−0.09, 0.08) 0.01 (−0.08, 0.10) − 0.04 (−0.14, 0.05) − 0.08 (−0.18, 0.01)
Quantity of F&V − 0.11 (−0.19, − 0.03) − 0.11 (−0.20, − 0.03) 0.01 (−0.07, 0.09) − 0.01 (−0.08, 0.10)
Quantity of fruit − 0.11 (−0.19, − 0.03) − 0.12 (−0.20, − 0.03) 0.01 (−0.07, 0.09) 0.01 (−0.10, 0.07)
Quantity of vegetable − 0.05 (−0.13, 0.03) − 0.05 (−0.13, 0.03) 0.01 (−0.07, 0.09) 0.04 (−0.05, 0.12)
TG (mmol/l)
Plasma vitamin C 0.01 (−0.08, 0.10) − 0.01 (−0.10, 0.08) − 0.08 (−0.18, 0.01) − 0.11 (−0.21, − 0.01)
Quantity of F&V 0.01 (−0.09, 0.08) − 0.05 (−0.14, 0.03) − 0.07 (−0.15, 0.02) − 0.09 (−0.18, 0.00)
Quantity of fruit − 0.05 (−0.14, 0.03) − 0.08 (−0.17, 0.00) − 0.06 (−0.15, 0.02) − 0.10 (−0.19, − 0.01)
Quantity of vegetable 0.07 (−0.01, 0.15) 0.03 (−0.06, 0.11) − 0.03 (−0.12, 0.05) − 0.03 (−0.12, 0.06)
HDL-c (mmol/l)
Plasma vitamin C 0.00 (−0.02, 0.03) 0.02 (−0.01, 0.04) 0.03 (0.00, 0.05) 0.04 (0.01, 0.06)
Quantity of F&V − 0.01 (−0.03, 0.01) − 0.01 (−0.03, 0.01) 0.03 (0.01, 0.06) 0.04 (0.01, 0.06)
Quantity of fruits 0.00 (−0.03, 0.02) − 0.00 (−0.02, 0.02) 0.03 (0.00, 0.05) 0.03 (0.01, 0.05)
Quantity of vegetables − 0.02 (−0.04, 0.00) − 0.01 (−0.03, 0.01) 0.02 (0.00, 0.05) 0.02 (0.00, 0.05)
CCMR
Plasma vitamin C − 0.02 (−0.07, 0.02) − 0.04 (−0.08, 0.00) − 0.05 (−0.09, 0.00) − 0.07 (−0.12, − 0.03)
Quantity of F&V − 0.03 (−0.07, 0.01) − 0.04 (−0.08, − 0.01) − 0.02 (−0.06, 0.01) − 0.03 (−0.07, 0.01)
Quantity of fruit − 0.04 (−0.08, 0.00) − 0.04 (−0.08,− 0.01) − 0.01 (−0.05, 0.03) − 0.04 (−0.08, 0.00)
Quantity of vegetable 0.01 (−0.03, 0.05) − 0.02 (−0.06, 0.02) − 0.02 (−0.06, 0.02) − 0.01 (−0.05, 0.03)
Abbreviations: CCMR, clustered cardiometabolic risk score; F&V, fruits and vegetables; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; SBP, systolic
blood pressure; TG, triglycerides. Model 1: adjusted for age and sex. Model 2: model 1+intervention group, occupational socio-economic status, baseline and
follow-up smoking status, physical activity, alcohol intake, total energy intake (except plasma vitamin C), blood pressure-lowering (for SBP and CCMR), glucose-
lowering medication (for HbA1c and CCMR) and lipid-lowering medication (for TG, HDL-c and CCMR) and change in variety of intake (except plasma vitamin C).
Between baseline and 1 year, one s.d. plasma vitamin C= 23.40 μmol/l; quantity F&V= 249.91 g; quantity of fruit= 191.61 g; quantity of vegetable= 151.28 g.
Between 1 and 5 years, one s.d. plasma vitamin C= 22.54 μmol/l; quantity of F&V= 270.05 g; quantity of fruit= 196.66 g; quantity of vegetables= 131.54 g.
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per day (1 s.d. in our study), they would experience an
approximate reduction in waist circumference of 1 cm – the
beneﬁt of which would be a 2% reduction in the risk of
cardiovascular event.27
Although the associations between plasma vitamin C levels and
cardiovascular risk factor levels were not discrepant with those for
quantity of F&V intake, there are several reasons that might
explain why the associations were weaker for plasma vitamin C
when the opposite might have been expected.9 First, because an
increasing number of foods are enriched with vitamin C, F&V can
no longer be assumed to be the main source of intake of this
vitamin. Second, plasma levels of vitamin C plateau at the upper
end of the normal range,28 meaning that any additional increase
in intake will not be correctly reﬂected in plasma levels. Finally, a
number of factors such as physical activity, BMI and the efﬁciency
with which the body metabolises vitamin C, which is partially
genetically determined, have all been associated with plasma
vitamin C levels.29 Thus, to gain a better understanding of the
association between F&V intake and cardiovascular risk factor
levels, future studies should use a complementary approach in
which several F&V biomarkers are used in combination, as has
been done previously.30
Although the mechanisms by which F&V might improve
cardiovascular risk factor levels are not yet fully understood, there
are several plausible hypotheses. F&V provide an abundant source
of vitamins, minerals and phytochemicals that could help reduce
cardiovascular risk factor levels, by acting both alone and in
synergy, by counteracting the potentially harmful effects of
oxidative stress.31 A second explanation could be that because
F&V generally have a low energy content any increase in intake
could displace energy-dense foods from the diet,32 thereby aiding
weight loss.
Strengths and limitations
Our study has a number of important strengths, including the
population-based study design, use of repeat measures of all
exposures and outcomes over 5 years of follow-up and
complementary analyses using plasma vitamin C as an objective
biomarker of F&V intake. Although it is known that F&V intake
reported using an FFQ generally leads to an overestimation of
intake in comparison with a 7-day dietary recall questionnaire,33
an additional major strength of our study is that we used the FFQ
across time points to estimate change in intake, for which it has
been shown to be equally as valid as multiple 24-h recalls.34
However, as with any self-reported measure, FFQs may be
vulnerable to recall and social desirability biases. We were also
able to adjust for a wide range of potential confounders, reducing
the likelihood that our ﬁndings are explained by confounding.
Table 3. Associations between changes in variety of F&V intake (per s.d.) and cardiometabolic risk factors at the relevant follow-up time point,
presented as regression coefﬁcients (and 95% conﬁdence intervals) per 1 s.d. increase in the exposure, estimated from linear mixed models
Baseline to 1 year 1–5 years
Model 1 Model 2 Model 1 Model 2
Waist (cm)
Variety of F&V 0.18 (−0.51, 0.88) 0.18 (−0.46, 0.83) 0.20 (−0.50, 0.89) 0.53 (−0.12, 1.18)
Variety of fruit − 0.46 (−1.16, 0.25) 0.09 (−0.59, 0.76) 0.45 (−0.26, 1.15) 0.42 (−0.23, 1.07)
Variety of vegetable 0.56 (−0.13, 1.25) 0.23 (−0.41, 0.88) − 0.03 (−0.68, 0.69) 0.42 (−0.24, 1.07)
SBP (mm Hg)
Variety of F&V − 0.59 (−2.17, 1.00) − 0.60 (−0.21, 1.01) − 0.00 (−1.58, 1.58) − 0.17 (−1.79, 1.45)
Variety of fruit − 0.79 (−2.38, 0.79) − 0.52 (−2.20, 1.15) − 0.16 (−1.43, 1.74) − 0.19 (−1.81, 1.43)
Variety of vegetable − 0.24 (−1.81, 1.34) − 0.41 (−2.02, 1.19) − 0.11 (−1.69, 1.46) 0.13 (−1.50, 1.75)
HbA1c(%)
Variety of F&V − 0.05 (−0.13, 0.03) − 0.05 (−0.13, 0.04) 0.07 (−0.01, 0.15) 0.07 (−0.01, 0.16)
Variety of fruit − 0.07 (−0.15, 0.01) − 0.03 (−0.12, 0.06) 0.07 (−0.01, 0.15) 0.06 (−0.02, 0.14)
Variety of vegetable − 0.01 (−0.09, 0.07) − 0.05 (−0.13, 0.04) 0.05 (−0.03, 0.13) 0.05 (−0.03, 0.14)
TG (mmol/l)
Variety of F&V − 0.01 (−0.09, 0.07) 0.00 (−0.08, 0.08) 0.03 (−0.06, 0.11) 0.06 (−0.02, 0.15)
Variety of fruit − 0.04 (−0.13, 0.04) − 0.02 (−0.11, 0.06) 0.01 (−0.07, 0.09) 0.04 (−0.05 0.12)
Variety of vegetable 0.02 (−0.07, 0.10) 0.02 (−0.07, 0.10) 0.03 (−0.05, 0.11) 0.05 (−0.03, 0.13)
HDL-c (mmol/l)
Variety of F&V 0.01 (−0.03, 0.02) − 0.01 (−0.03, 0.01) 0.00 (−0.03, 0.02) − 0.01 (−0.03, 0.01)
Variety of fruit 0.01 (−0.01, 0.03) − 0.01 (−0.04, 0.01) − 0.00 (−0.03, 0.02) − 0.01 (−0.03, 0.01)
Variety of vegetable − 0.02 (−0.04, 0.01) − 0.00 (−0.03, 0.02) 0.00 (−0.02, 0.02) − 0.01 (−0.03, 0.01)
CCMR
Variety of F&V − 0.01 (−0.05, 0.03) 0.00 (−0.03, 0.04) 0.01 (−0.03, 0.05) 0.02 (−0.01, 0.06)
Variety of fruit − 0.05 (−0.09, − 0.01) −0.00 (−0.04, 0.04) 0.02 (−0.01, 0.06) 0.02 (−0.02, 0.06)
Variety of vegetable 0.03 (−0.01, 0.07) 0.01 (−0.03, 0.05) 0.00 (−0.04, 0.04) 0.02 (−0.02, 0.06)
Abbreviations: CCMR, clustered cardiometabolic risk scores; F&V, fruits and vegetables; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; SBP, systolic
blood pressure; TG, triglycerides. Model 1: adjusted for age and sex. Model 2: model 1+intervention group, occupational socio-economic status, baseline and
follow-up smoking status, physical activity, alcohol intake, blood pressure-lowering (for SBP and CCMR), glucose-lowering medication (for HbA1c
and CCMR) and lipid-lowering medication (for TG, HDL-c and CCMR) and change in quantity of intake. Between baseline and 1 year, one s.d. variety of fruit and
vegetables= 4.3 items; variety of fruit= 2.3 items; variety of vegetables= 3.1 items. Between 1 and 5 years, one s.d. variety fruit and vegetables= 4.6 items;
variety of fruit= 2.2 items; variety of vegetables= 3.3 items.
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The limitations of our study also warrant discussion. Our
analyses were limited to only 46% of the original ADDITION-
Cambridge study population because of missing data at one or
more of the follow-up clinic visits. Excluded participants
reported having a lower intake of F&V, a larger waist
circumference and higher HbA1c levels at baseline. However,
when we performed multiple imputation analyses the results
were similar, suggesting that bias due to missing data is unlikely.
In addition, because of the number of hypothesis tests
conducted, statistically signiﬁcant results may have occurred
solely because of the play of chance. As the majority of our
population is white and middle-aged, the generalisability of our
ﬁndings to other ethnicities and age groups requires caution.
Furthermore, because of the lack of heterogeneity in variety
of F&V intake observed in our study cohort, we cannot rule
out variety in intake as playing an important role in CVD – we
therefore suggest that this be studied in future cohorts.
CONCLUSIONS
Increased intake of F&V early in the course of diabetes is
associated with improvements in a number of important
cardiovascular risk factors. It will be beneﬁcial to investigate why
the early increases in F&V intake are not maintained in the longer
term, and future research should focus on identifying strategies to
help patients maintain improvements in diet.
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